Filing Details
- Accession Number:
- 0001209191-13-056717
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-12 19:00:20
- Reporting Period:
- 2013-12-10
- Filing Date:
- 2013-12-12
- Accepted Time:
- 2013-12-12 19:00:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1466301 | Clovis Oncology Inc. | CLVS | Pharmaceutical Preparations (2834) | 900475355 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1051411 | T Erle Mast | C/O Clovis Oncology, Inc. 2525 28Th Street, Suite 100 Boulder, CO 80301 | Executive Vp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-12-10 | 25,177 | $53.81 | 193,406 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-12-10 | 700 | $54.57 | 192,706 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-12-11 | 24,023 | $51.64 | 168,683 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-12-11 | 100 | $52.38 | 168,583 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $53.53 to $54.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $54.53 to $54.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $51.35 to $52.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
